REGENXBIO, Inc. (RGNX)
8.245
+0.26
(+3.32%)
USD |
NASDAQ |
Sep 17, 16:00
8.245
0.00 (0.00%)
After-Hours: 20:00
REGENXBIO Total Return Level : 7.98 for Sept. 16, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 16, 2026 | 7.98 |
| September 15, 2026 | 7.945 |
| September 14, 2026 | 8.69 |
| September 11, 2026 | 8.53 |
| September 10, 2026 | 8.56 |
| September 09, 2026 | 8.73 |
| September 08, 2026 | 8.76 |
| September 04, 2026 | 8.94 |
| September 03, 2026 | 9.20 |
| September 02, 2026 | 9.60 |
| September 01, 2026 | 9.32 |
| August 31, 2026 | 9.50 |
| August 28, 2026 | 9.66 |
| August 27, 2026 | 9.37 |
| August 26, 2026 | 9.38 |
| August 25, 2026 | 8.91 |
| August 24, 2026 | 8.055 |
| August 21, 2026 | 10.72 |
| August 20, 2026 | 11.06 |
| August 19, 2026 | 12.02 |
| August 18, 2026 | 11.07 |
| August 17, 2026 | 11.33 |
| August 14, 2026 | 10.76 |
| August 13, 2026 | 10.66 |
| August 12, 2026 | 10.91 |
| Date | Value |
|---|---|
| August 11, 2026 | 10.65 |
| August 10, 2026 | 10.42 |
| August 07, 2026 | 10.72 |
| August 06, 2026 | 11.28 |
| August 05, 2026 | 10.50 |
| August 04, 2026 | 10.30 |
| August 03, 2026 | 9.96 |
| July 31, 2026 | 9.69 |
| July 30, 2026 | 10.12 |
| July 29, 2026 | 9.62 |
| July 28, 2026 | 9.60 |
| July 27, 2026 | 9.71 |
| July 24, 2026 | 9.73 |
| July 23, 2026 | 10.25 |
| July 22, 2026 | 10.20 |
| July 21, 2026 | 10.34 |
| July 20, 2026 | 10.32 |
| July 17, 2026 | 9.89 |
| July 16, 2026 | 11.20 |
| July 15, 2026 | 12.27 |
| July 14, 2026 | 12.29 |
| July 13, 2026 | 12.75 |
| July 10, 2026 | 13.95 |
| July 09, 2026 | 15.65 |
| July 08, 2026 | 15.23 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| AbbVie, Inc. | 452.17 |
| Capricor Therapeutics, Inc. | 8.56 |
| United Therapeutics Corp. | 498.48 |
| Ardelyx, Inc. | 3.39 |
| Biomea Fusion, Inc. | 1.74 |